First Mark Ultra Foaming Antibacterial Solution
NDC 51042-001
Product Information
First Mark Ultra Foaming Antibacterial (benzalkonium chloride) is a OTC MONOGRAPH DRUG-approved product labeled by Performance Food Group. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a solution for topical administration. This product entry covers the primary NDC 51042-001 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 51042-001?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- BENZALKONIUM (UNII: 7N6JUD5X6Y) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- COCAMINE OXIDE (UNII: QWA2IZI6FI)
- HEXYLENE GLYCOL (UNII: KEH0A3F75J)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- COCAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: H2KVQ74JM4)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) (UNII: 0L414VCS5Y)
- MYRISTIC DIISOPROPANOLAMIDE (UNII: 17DN142CTK)
- MYRISTAMINE OXIDE (UNII: J086PM3RRT)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- METHYL GLUCETH-20 (UNII: J3QD0LD11P)
- GLYCERYL CAPRYLOCAPRATE (UNII: U72Q2I8C85)
- ALCOHOL (UNII: 3K9958V90M)
- PEG-12 DIMETHICONE (UNII: ZEL54N6W95)
- POTASSIUM CITRATE (UNII: EE90ONI6FF)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
* Please review the full disclaimer at the bottom of this page.